IDEAYA Biosciences (IDYA) Consolidated Net Income (2020 - 2025)
Historic Consolidated Net Income for IDEAYA Biosciences (IDYA) over the last 6 years, with Q3 2025 value amounting to $108.5 million.
- IDEAYA Biosciences' Consolidated Net Income rose 26212.76% to $108.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$35.7 million, marking a year-over-year increase of 8412.22%. This contributed to the annual value of -$327.0 million for FY2024, which is 14323.25% down from last year.
- According to the latest figures from Q3 2025, IDEAYA Biosciences' Consolidated Net Income is $108.5 million, which was up 26212.76% from -$144.1 million recorded in Q4 2024.
- In the past 5 years, IDEAYA Biosciences' Consolidated Net Income ranged from a high of $108.5 million in Q3 2025 and a low of -$144.1 million during Q4 2024
- Moreover, its 5-year median value for Consolidated Net Income was -$26.3 million (2023), whereas its average is -$27.4 million.
- As far as peak fluctuations go, IDEAYA Biosciences' Consolidated Net Income tumbled by 517969.7% in 2023, and later surged by 26212.76% in 2025.
- IDEAYA Biosciences' Consolidated Net Income (Quarter) stood at -$18.4 million in 2021, then crashed by 43.95% to -$26.4 million in 2022, then plummeted by 58.52% to -$41.9 million in 2023, then plummeted by 243.87% to -$144.1 million in 2024, then surged by 175.24% to $108.5 million in 2025.
- Its Consolidated Net Income was $108.5 million in Q3 2025, compared to -$144.1 million in Q4 2024 and -$66.9 million in Q3 2024.